Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New PET scan aims to spot hidden cancers with precision

NCT ID NCT02293954

First seen Nov 15, 2025 · Last updated Jun 16, 2026 · Updated 19 times

Summary

This study tests a special PET scan that uses a radioactive antibody (64Cu-M5A) to find cancers that produce a protein called CEA. The goal is to see if this scan can detect tumors that standard methods might miss. About 20 adults with CEA-positive cancers (such as breast, colon, lung, or pancreatic cancer) will receive the injection and have scans on day 1 and day 2.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • City of Hope Medical Center

    Duarte, California, 91010, United States

Conditions

The condition(s) this trial relates to.

bile duct neoplasm breast cancer breast neoplasm cancer carcinoma of liver and intrahepatic biliary tract Carcinoma, Medullary colon carcinoma colonic neoplasm digestive system cancer digestive system neoplasm extrahepatic bile duct carcinoma gallbladder cancer gallbladder neoplasm hepatocellular carcinoma lung cancer lung neoplasm malignant pancreatic neoplasm medullary thyroid gland carcinoma metastatic malignant neoplasm Neoplasm Metastasis pancreatic neoplasm rectal cancer rectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.